Science topic
Sexual Dysfunctions - Science topic
Explore the latest questions and answers in Sexual Dysfunctions, and find Sexual Dysfunctions experts.
Questions related to Sexual Dysfunctions
We are using logistic regression analysis.
FSFI questionnaire does not assess female sexual function, but primarily assesses vaginal intercourse. In fact, the decline of desire, decreased interest in sex and reduced ability to achieve orgasm are associated specifically with penile-vaginal intercourse. To assess sexual function in women, the words “intercourse” and “satisfaction” must not appear in the questions. The questionnaire must assess the presence or absence of orgasm (a function of the human body, which must be assessed in the subject) with masturbation. The female orgasm is caused by female erectile organs: clitoris (glans, body, crura), vestibular bulbs, corpus spongiosum of the female urethra, and labia minora. Effective sexual stimulation allows orgasm and multiple orgasms in women. The clitoral sexual response is not affected by aging and for this reason women have the physical capability of being orgasmic at all ages. Is Female Sexual Function Index questionnaire constructed by sexual medicine experts under the influence of drug companies?
By comparing total scores (better the score, better the sexual function) or by determining the rate of dysfunctional women in each group using the cutt-off of 26?
Since one of the main side effect of abusing drugs is sexual dysfunction and the false belief of addicts of the opposite studying this point in arab cultures will help in correcting this mess
Trying to see the role calcium ion channels may play in rare causes of sexual dysfunction. When people are suffering from hyperparathyroidism their symptoms are thought to be caused by calcium channel overload. Is this also the same reason for the sexual symptoms? Developing research for the role of Calcium Channels and Post SSRI Sexual Dysfunction Syndrome (PSSD).
Hi I am doing a lit review on this topic, any suggestions welcome!
Thank you!
I'm interested in SAST (or any version.. SAST-R etc.) in language other than English and Polish.
I suspect that there's lots of good practice across Europe but that it is not being translated between settings and healthcare systems. Is anyone working on improving primary care diagnosis and treatment of sexual dysfunction? There are networks for primary care, cancer, sexual dysfunction but what about a network for primary care identification and treatment of sexual dysfunction following cancer?
Such a network could engage clinicians from primary, secondary and tertiary care, not only with an interest in cancer, academics from a range of disciplines, patients and patient groups, policy makers.
Substitution strategies could highly alleviate patients with serotonin-related sexual dysfunction but are non serotonergic drugs so effective in these patients?
Want to evaluate sexual dysfunction in CKD and improvement after kidney transplant. Does anyone have a validated questionnaire for the patient on this?
Now, I am afert my PhD defense and I am looking for articles relating to sexual dysfunctions in patients with ED. I would like to prepare a new research project concerning these problems
What is the cutoff score for the individual items on Nowinski and Lopiccolo's Sexual History Form? And for the Global Sexual Functioning (Creti et al, 1998) score, what is the normal functioning score and poor functioning score? Where can I find the normative scores?
In the last year i have had four male patients complaining of persistent sexual dysfunction (> 6 mos) marked by erectile difficulties (partial erections/diminished nocturnal tumescence), penile numbness (genital anesthesia), and diminished orgasm following SSRI and SNRI therapy. All of the side effects were present during therapy. All of the patients report not having had sexual dysfunction prior to initiation of therapy with one case being corroborated by the patient's wife. The literature has case reports and a least one review article on the subject. If this is true, it is counter to the informed consent we typically present to patients, namely that discontinuation (or additional time on therapy) leads to side effect resolution. My question is has anyone else had similar cases or assessed for such symptoms? If so how long did such side effects last and did any interventions work?
We submitted our manuscript to PlosONE. However, the journal has a hard time to find peer reviewers. Therefore, I decided to post the manuscript here and make it available to all of you for open review. How to review? On the manuscript page, you can click the button "Review". https://www.researchgate.net/publication/264230833_Dapoxetine_for_Premature_Ejaculation_a_Systematic_Review_and_Meta-analysis
Substantial contributions will be acknowledged in a revised manuscript that may be submitted for regular publication.
Thank you
Frederik
I'm developing a program to help women assess and improve the quality of their sexuality regarding self image and with partners.
I am looking for a simple screening tool for sexual dysfunction in general practice, to be administered as part of a comprehensive health assessment for older veterans. Thanks for your help.
Many psychotic patients have predominantly masturbation sexual activity without sexual relationships with a partner. Sexual dysfunction could lead to drop-outs. Would you prefer non hyperprolactinaemic drugs (aripiprazole, quetiapine, ect.) instead of hyperprolactinaemic ones (risperidone, paliperidone and amisulpride) in these patients?
If you were in charge of doing research in females with sexual dysfunction, what question/s would you ask and what information would you want from them?